Streamlining Genetic Testing Prior Auth with SMART on FHIR Integration

The Challenge of Genetic Testing Prior Authorization

Genetic testing, while crucial for precision medicine, is frequently subject to stringent prior authorization requirements due to its cost and rapidly evolving clinical guidelines. This includes high-volume categories such as hereditary cancer panels, prenatal genetic testing, and pharmacogenomics. Manual PA processes for these tests often lead to delays, clinician burnout, and inconsistent documentation, especially when interacting with specialized RBMs.

The Klivira SMART on FHIR Advantage for Genomics

Klivira's SMART on FHIR integration transforms the genetic testing prior auth workflow by embedding it directly within your EMR. This eliminates the need for clinicians to navigate separate portals or re-enter patient data, reducing administrative burden and improving the accuracy of submissions. By standardizing the PA process, we ensure that critical genetic insights are accessible to patients without unnecessary delays.

Key Benefits of In-EMR Genetic Testing Prior Auth

• **Automated Context Transfer:** Patient and encounter data are automatically pulled from your EMR (e.g., Epic, Cerner, athenahealth, MEDITECH) via SMART on FHIR, ensuring accurate submissions for hereditary cancer panels and other genetic tests.
• **Reduced Context-Switching:** Clinicians initiate and complete prior authorizations for genetic testing without leaving their native EMR environment, minimizing disruption to their workflow.
• **FHIR-Native Data Exchange:** Klivira reads US Core resources from the EHR's FHIR endpoint and leverages Da Vinci CRD, DTR, and PAS for coverage discovery, documentation assembly, and submission, eliminating manual data entry errors.
• **Structured PA Status Write-Back:** Prior authorization decisions and status updates are written back to the EMR as structured FHIR resources (DocumentReference, Communication, Task), providing queryable, real-time insights into genetic testing approvals.
• **RBM and Payer Connectivity:** Seamlessly connect to a broad network of payers and RBMs, including eviCore and Avalon Healthcare Services, to manage prior authorizations for genetic testing.

Addressing Specific Genetic Testing PA Triggers

Genetic testing prior authorization is often triggered by specific order types within the EMR, such as advanced molecular diagnostics, high-cost pharmacogenomic panels, or comprehensive hereditary cancer screenings. Klivira's system identifies these triggers at the point of order entry, initiating a SMART on FHIR-launched workflow that guides the clinician or coordinator through the necessary steps. This ensures compliance with payer policies, which are frequently informed by clinical guideline bodies like NCCN or ASCO.

Klivira's Conformance to Prior Auth Standards

Klivira is built on industry-leading standards to ensure robust and future-proof prior authorization automation. Our platform supports SMART App Launch for secure, in-EMR application deployment and leverages the Da Vinci Implementation Guides, including Coverage Requirements Discovery (CRD), Documentation Templates and Rules (DTR), and Prior Authorization Support (PAS). This commitment ensures interoperability and efficient data exchange for all genetic testing prior authorizations.

EMR and Payer Ecosystem Integration

Klivira integrates with leading EMR systems such as Epic, Cerner, athenahealth, and MEDITECH, ensuring a consistent experience across diverse clinical environments. For genetic testing, this means seamless interaction with payer portals and RBMs like eviCore and Avalon Healthcare Services, which frequently manage authorizations for complex genetic panels. Our platform streamlines the exchange of clinical documentation, such as genetic counseling notes and family history, directly from the EMR to the payer.